Results 41 to 50 of about 732,366 (171)

Echocardiographic Imaging to Guide Tricuspid Interventions

Structural Heart
Transcatheter tricuspid valve interventions may offer patients less invasive treatment alternatives to surgery. This review evaluates the use of echocardiography to determine anatomic suitability and guide the 2 most common classes of device currently ...
Rebecca T. Hahn, MD
doaj   +1 more source

Transcatheter Tricuspid Valve-in-Valve Replacement Using a J-Valve System for a Failed Tricuspid Bioprosthesis

, 2022
BACKGROUND: Redo operation for failed tricuspid bioprosthetic valves is associated with high morbidity and mortality. Transcatheter tricuspid valve-in-valve implantation has become an acceptable option for high-risk patients with a failed tricuspid ...
Miao, Lifu, Tang, Xiujie, Zhang, Mingkui, Xue, Hui, Xiujie Tang, Lifu Miao, Hui Xue, Yanbin Shao, Shao, Yanbin, Mingkui Zhang   +9 more
core   +1 more source

Successful Percutaneous Retrieval of an Embolized MitraClip From the Right Subclavian Artery

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Single leaflet device attachment (SLDA) after mitral transcatheter valve edge‐to‐edge repair (M‐TEER) has been reported in up to 5% of patients. However, complete embolization of the M‐TEER device is exceedingly rare. Device retrievals in all previously reported cases were completed by vascular surgery cut down at the end. In this case, we are
Seyed Hossein Aalaei‐Andabili, Diljon S. Chahal, Shahab Tour Savadkohi   +2 more
wiley   +1 more source

Resurgence of the Tricuspid Valve: A Comprehensive Review of Transcatheter Interventions

Indian Journal of Clinical Cardiology
Tricuspid valve, once considered a “forgotten valve,” is experiencing a remarkable resurgence in clinical practice. Previously viewed as a secondary consequence of left-sided heart disease, tricuspid regurgitation is now recognized as an independent ...
Krishna Santhosh Vemuri, Tejaswi Penta, Deepak Sherpally, Bhavanadhar Penta   +3 more
doaj   +1 more source

Transcatheter Tricuspid Valve-in-Valve Replacement with an Edwards Sapien 3 Valve [PDF]

, 2017
A few case reports and case series have documented the outcomes in patients with tricuspid bioprosthetic valvular degeneration who underwent transcatheter implantation of the Medtronic Melody and the Edwards Sapien XT and Sapien 3 valves. In this report,
Pranav Loyalka, Gregoric, Igor D, Nascimbene, Angelo, Kar, Biswajit, Ajay Sundara Raman, Loyalka, Pranav, Biswajit Kar, Angelo Nascimbene, Raman, Ajay Sundara, Benjamin Metz, Igor D. Gregoric, Metz, Benjamin   +11 more
core   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Advances in transcatheter mitral and tricuspid therapies

BMC Cardiovascular Disorders, 2020
Background While rheumatic mitral stenosis has been effectively treated percutaneously for more than 20 years, mitral and tricuspid regurgitation treatment appear as a contemporary unmet need.
Pavel Overtchouk, Nicolo Piazza, Juan Granada, Osama Soliman, Bernard Prendergast, Thomas Modine   +5 more
doaj   +1 more source

Transcatheter Tricuspid Valve Replacement With a Dedicated Device in a Patient With 2 Endocardial Leads

JACC: Case Reports, 2023
A 79-year-old woman with a history of dilated cardiomyopathy who required a permanent peacemaker, recently upgraded to implantable cardioverter-defibrillator cardiac resynchronization therapy, was admitted for right heart failure.
Rodrigo Estevez-Loureiro, MD, PhD, Manuel Barreiro-Pérez, MD, PhD, Miguel Piñon, MD, PhD, Rocío González, MD, PhD, David Dobarro, MD, PhD, Thomas Modine, MD, PhD, Anson Cheung, MD, PhD, Jose A. Baz-Alonso, MD, Berenice Caneiro-Queija, MD, Andrés Íñiguez-Romo, MD, PhD   +9 more
doaj   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

A Systematic Review of the Design, Method of Implantation and Early Clinical Outcomes of Transcatheter Tricuspid Prostheses

Reviews in Cardiovascular Medicine, 2023
Background: Intervention for tricuspid regurgitation (TR) tends to happen concurrently with and is addressed during mitral valve surgery. Isolated TR interventions, however, are not unusual and are becoming more common.
Faizus Sazzad, Yinling Zhu, Hwa Liang Leo, Jie Hui Nah, Hui Ying Ang, Chuen Neng Lee, Jimmy Kim Fatt Hon   +6 more
doaj   +1 more source